LncARSR proves to be involved in NAFLD and HCC through the regulation of the YAP1/IRS2/AKT axis, while silencing its expression seems to reduce lipid accumulation in the NAFLD mice model [235]. The gene discussed is LNCARSR; the disease is metabolic dysfunction-associated steatotic liver disease.